A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

IsraelRecruitingPHASE3

Conditions

Triple Negative Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • USA Mitchell Cancer Institute ( Site 0090), Mobile, Alabama, United States

    Study coordinator · 251-410-4924
  • Ironwood Cancer & Research Centers ( Site 0036), Chandler, Arizona, United States

    Study coordinator · 623-312-3000
  • City of Hope ( Site 0097), Duarte, California, United States

    Study coordinator · 626-218-9845
  • City of Hope Lennar Foundation Cancer Center ( Site 0099), Irvine, California, United States

    Study coordinator · 626-218-0720
  • UCLA Department of Medicine - Hematology & Oncology ( Site 0047), Los Angeles, California, United States

    Study coordinator · 650-283-5067
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0016), San Francisco, California, United States

    Study coordinator · 415-353-7070
  • Yale New Haven Hospital ( Site 0001), New Haven, Connecticut, United States

  • Washington Hospital Center ( Site 0098), Washington D.C., District of Columbia, United States

    Study coordinator · 202-877-8839
  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs, Florida, United States

    Study coordinator · 407-303-2284
  • Orlando Health Cancer Institute ( Site 0012), Orlando, Florida, United States

    Study coordinator · 321-841-8284
  • Florida Cancer Specialists - East ( Site 7000), West Palm Beach, Florida, United States

    Study coordinator · 561-366-4100
  • University Cancer & Blood Center, LLC ( Site 0023), Athens, Georgia, United States

    Study coordinator · 706-353-2990
  • St. Luke's Cancer Institute: Boise ( Site 0037), Boise, Idaho, United States

    Study coordinator · 208-381-2711
  • University of Illinois Cancer Center ( Site 0044), Chicago, Illinois, United States

    Study coordinator · 312-996-1581
  • MedStar Franklin Square Medical Center ( Site 0031), Baltimore, Maryland, United States

    Study coordinator · 443-777-7147
  • MedStar Good Samaritan Hospital ( Site 0079), Baltimore, Maryland, United States

    Study coordinator · 443-777-7147
  • MedStar Southern Maryland Hospital Center ( Site 0100), Clinton, Maryland, United States

    Study coordinator · 301-877-4673
  • MedStar Montgomery Medical Center ( Site 0078), Olney, Maryland, United States

    Study coordinator · 301-774-8882
  • Holy Cross Hospital ( Site 0091), Silver Spring, Maryland, United States

    Study coordinator · 301-754-7552
  • Cancer & Hematology Centers of Western Michigan ( Site 0026), Grand Rapids, Michigan, United States

    Study coordinator · 616-954-9800
  • Allina Health Cancer Institute ( Site 0069), Minneapolis, Minnesota, United States

    Study coordinator · 763-577-7000
  • Comprehensive Cancer Centers of Nevada ( Site 0015), Las Vegas, Nevada, United States

    Study coordinator · 702-952-3350
  • Renown Regional Medical Center ( Site 0005), Reno, Nevada, United States

    Study coordinator · 775-982-5050
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0082), Hackensack, New Jersey, United States

    Study coordinator · 551-996-5900
  • New Mexico Oncology Hematology Consultants Ltd. ( Site 0019), Albuquerque, New Mexico, United States

    Study coordinator · 505-842-8171
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073), Mineola, New York, United States

    Study coordinator · 516-663-9500
  • Laura and Isaac Perlmutter Cancer Center ( Site 0003), New York, New York, United States

    Study coordinator · 212-731-6126
  • UNC REX Cancer Center ( Site 0071), Raleigh, North Carolina, United States

    Study coordinator · 919-784-7209
  • SCRI Oncology Partners ( Site 7004), Nashville, Tennessee, United States

    Study coordinator · 615-329-7274
  • Tennessee Oncology ( Site 0018), Nashville, Tennessee, United States

    Study coordinator · 877-836-6662
  • Texas Oncology - DFW ( Site 8007), Dallas, Texas, United States

    Study coordinator · 214-739-4175
  • Texas Oncology - West Texas ( Site 8004), El Paso, Texas, United States

    Study coordinator · 915-747-4835
  • Kelsey-Seybold Clinic - North Houston Campus ( Site 0096), Houston, Texas, United States

    Study coordinator · 713-239-4510
  • Kelsey-Seybold Clinic ( Site 0040), Houston, Texas, United States

    Study coordinator · 713-239-4510
  • Texas Oncology - San Antonio ( Site 8001), San Antonio, Texas, United States

    Study coordinator · 210-419-2608
  • University of Utah, Huntsman Cancer Institute ( Site 0056), Salt Lake City, Utah, United States

    Study coordinator · 801-587-7000
  • Virginia Oncology Associates (VOA) ( Site 8002), Norfolk, Virginia, United States

    Study coordinator · 757-368-5033
  • Fred Hutchinson Cancer Center ( Site 0042), Seattle, Washington, United States

    Study coordinator · 206-606-6329
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 2401), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +54 9223 593 7663
  • Instituto Alexander Fleming ( Site 2402), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +541132218900
  • Hospital Italiano de Cordoba ( Site 2406), Córdoba, Córdoba Province, Argentina

    Study coordinator · +543514106550
  • Clinica Viedma ( Site 2403), Viedma, Río Negro Province, Argentina

    Study coordinator · 54 9351 592 3598
  • Fundacion Estudios Clinicos ( Site 2405), Rosario, Santa Fe Province, Argentina

    Study coordinator · +54 9346 69 9922
  • Hospital Provincial del Centenario ( Site 2410), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414307185
  • Fundacion Centro Oncologico de Integración Regional ( Site 2400), Mendoza, Argentina

    Study coordinator · +54 9261 367 9497
  • Blacktown Hospital ( Site 5500), Blacktown, New South Wales, Australia

    Study coordinator · +61298818000
  • Peninsula Health Frankston Hospital ( Site 5501), Frankston, Victoria, Australia

    Study coordinator · +61397848520
  • ZAS Sint Augustinus ( Site 3102), Antwerp, Flanders, Belgium

    Study coordinator · 003234433759
  • Ziekenhuis Oost Limburg ( Site 3105), Genk, Limburg, Belgium

    Study coordinator · 089 32 50 50
  • AZ Maria Middelares ( Site 3103), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +32 9 246 95 16
  • UZ Gent ( Site 3101), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · 09 332 20 15
  • Hospital de Câncer de Recife ( Site 2300), Recife, Pernambuco, Brazil

    Study coordinator · +558132178084
  • Liga Norte Riograndense Contra o Cancer ( Site 2310), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +55 84 99817-0070
  • Hospital Nossa Senhora da Conceição ( Site 2302), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +55 51 35160954
  • Fundacao Pio XII - Hospital de Cancer de Barretos ( Site 2307), Barretos, São Paulo, Brazil

    Study coordinator · +55 17 3321-6637
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 2301), São Jose Do Rio Preto, São Paulo, Brazil

    Study coordinator · +55 (17) 3201-5054
  • IBCC - Núcleo de Pesquisa e Ensino ( Site 2306), São Paulo, Brazil

    Study coordinator · +55 11 98468-0001
  • Cross Cancer Institute ( Site 0216), Edmonton, Alberta, Canada

    Study coordinator · 7804328644
  • Lakeridge Health ( Site 0217), Oshawa, Ontario, Canada

    Study coordinator · 905-576-8711
  • North York General Hospital ( Site 0209), Toronto, Ontario, Canada

    Study coordinator · 416-756-6000
  • Princess Margaret Cancer Centre ( Site 0202), Toronto, Ontario, Canada

    Study coordinator · 416-946-2000
  • CIUSSS- saguenay-Lac-Saint-Jean ( Site 0213), Chicoutimi, Quebec, Canada

    Study coordinator · 418-541-1000
  • Centre Hospitalier de l'Université de Montréal ( Site 0208), Montreal, Quebec, Canada

    Study coordinator · 514-890-8444
  • Jewish General Hospital ( Site 0203), Montreal, Quebec, Canada

    Study coordinator · 514-340-8222
  • St. Marys Hospital Center ( Site 0201), Montreal, Quebec, Canada

    Study coordinator · 514-891-6904
  • McGill University Health Centre ( Site 0204), Montreal, Quebec, Canada

    Study coordinator · 514-299-6425
  • Hopital Du Saint-Sacrement ( Site 0210), Québec, Quebec, Canada

    Study coordinator · 4186827511
  • Saskatoon Cancer Centre ( Site 0215), Saskatoon, Saskatchewan, Canada

    Study coordinator · 306-655-2662
  • Biocenter ( Site 2009), Concepción, Biobio, Chile

    Study coordinator · +56412858421
  • IC La Serena Research ( Site 2007), La Serena, Coquimbo Region, Chile

    Study coordinator · +56512386127
  • FALP ( Site 2000), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56 9 6397 7440
  • Clínica UC San Carlos de Apoquindo ( Site 2008), Santiago, Region M. de Santiago, Chile

    Study coordinator · +569 5504 3334
  • Bradfordhill ( Site 2001), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56978878489
  • ONCOCENTRO APYS ( Site 2005), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56 9 92369820
  • The First Afflilated Hospital of Bengbu Medical College ( Site 5022), Bengbu, Anhui, China

    Study coordinator · 0552-3085746
  • The First Affiliated Hospital of Chongqing Medical University ( Site 5039), Chongqing, Chongqing Municipality, China

    Study coordinator · +86 023 89011606
  • Chongqing University Three Gorges Hospital ( Site 5020), Chongqing, Chongqing Municipality, China

    Study coordinator · 023-58103215
  • The First Affiliated hospital of Xiamen University ( Site 5035), Xiamen, Fujian, China

    Study coordinator · 0592-2137232
  • Sun Yat-Sen University Cancer Center ( Site 5014), Guangzhou, Guangdong, China

    Study coordinator · 020-87343990
  • Guangxi Medical University Affiliated Tumor Hospital. ( Site 5008), Nanning, Guangxi, China

    Study coordinator · +860771-5778582
  • Henan Cancer Hospital ( Site 5001), Zhengzhou, Henan, China

    Study coordinator · 0371-65588404
  • Tongji Hospital Tongji Medical Science & Technology ( Site 5007), Wuhan, Hubei, China

    Study coordinator · 027-83663940
  • Xiangyang Central Hospital ( Site 5017), Xiangyang, Hubei, China

    Study coordinator · 0710-2811523
  • Hunan Cancer Hospital ( Site 5002), Changsha, Hunan, China

    Study coordinator · 0731-88651669
  • Jiangsu Province Hospital ( Site 5009), Nanjing, Jiangsu, China

    Study coordinator · 02568308145
  • Xuzhou Central Hospital ( Site 5036), Xuzhou, Jiangsu, China

    Study coordinator · 051680812397
  • The First Hospital of Jilin University ( Site 5003), Changchun, Jilin, China

    Study coordinator · 0431-88783330
  • The First Affiliated Hospital of Xi an Jiaotong University ( Site 5005), Xi'an, Shaanxi, China

    Study coordinator · +8602985324094
  • Jinan Central Hospital ( Site 5031), Jinan, Shandong, China

    Study coordinator · 053155865197
  • LinYi Cancer Hospital ( Site 5021), Linyi, Shandong, China

    Study coordinator · +8605398127192
  • Shanxi Cancer Hospital ( Site 5043), Taiyuan, Shanxi, China

    Study coordinator · 03514881611
  • Sichuan Cancer Hospital. ( Site 5018), Chengdu, Sichuan, China

    Study coordinator · 028-85420251
  • The Second People's Hospital of Neijiang ( Site 5016), Neijiang, Sichuan, China

    Study coordinator · +86 0832 2380771
  • Affiliated Tumor Hospital of Xinjiang Medical University ( Site 5006), Ürümqi, Xinjiang, China

    Study coordinator · +8609917819133
  • The First Affiliated Hospital Zhejiang University School of Medicine ( Site 5026), Hangzhou, Zhejiang, China

    Study coordinator · 0571-87236855
  • Zhejiang Cancer Hospital ( Site 5012), Hangzhou, Zhejiang, China

    Study coordinator · 0571-88122222
  • The Second Affiliated hospital of Zhejiang University school of medicine ( Site 5024), Hangzhou, Zhejiang, China

    Study coordinator · 0571-89713252
  • Taizhou Hospital of Zhejiang Province ( Site 5029), Linhai, Zhejiang, China

    Study coordinator · 0576-85190467
  • Instituto de Cancerología ( Site 2206), Medellín, Antioquia, Colombia

    Study coordinator · +576043421010x1089
  • Centro Cancerologico del Caribe LTD ( Site 2209), Barranquilla, Atlántico, Colombia

    Study coordinator · +57 3132121774
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 2203), Bogotá, Bogota D.C., Colombia

    Study coordinator · +57 6017454421x90614
  • IMAT S.A.S ( Site 2202), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +576047862333
  • Oncologos Del Occidente ( Site 2208), Pereira, Risaralda Department, Colombia

    Study coordinator · 573154208077
  • Fakultni nemocnice Ostrava ( Site 3505), Ostrava - Poruba, Moravian-Silesian Region, Czechia

    Study coordinator · +420597372124
  • Vseobecna fakultni nemocnice v Praze ( Site 3501), Prague, Praha 2, Czechia

    Study coordinator · +420224966764
  • Masarykuv onkologicky ustav ( Site 3500), Brno, South Moravian, Czechia

    Study coordinator · +420543134003
  • Fakultni nemocnice Olomouc ( Site 3502), Olomouc, Czechia

    Study coordinator · +420588444295
  • Fakultni Thomayerova nemocnice ( Site 3506), Prague, Czechia

    Study coordinator · +420261083733
  • Fakultni nemocnice v Motole ( Site 3503), Prague, Czechia

    Study coordinator · +420224434700
  • Rigshospitalet University Hospital ( Site 3201), Copenhagen, Capital Region, Denmark

    Study coordinator · +4535453545
  • Herlev og Gentofte Hospital. ( Site 3205), Copenhagen, Capital Region, Denmark

    Study coordinator · +4538683868
  • Aarhus Universitets hospital ( Site 3204), Aarhus, Central Jutland, Denmark

    Study coordinator · + 4578450000
  • Odense Universitetshospital ( Site 3202), Odense, Region Syddanmark, Denmark

    Study coordinator · +4566113333
  • Oulun yliopistollinen sairaala-Oncology and Hematology ( Site 3304), Oulu, North Ostrobothnia, Finland

    Study coordinator · +35883153038
  • Tampereen yliopistollinen sairaala-Oncology ( Site 3302), Tampere, Pirkanmaa, Finland

    Study coordinator · +358331166764
  • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 3301), Helsinki, Uusimaa, Finland

    Study coordinator · +358947174900
  • CENTRE LEON BERARD ( Site 3004), Lyon, Auvergne-Rhône-Alpes, France

    Study coordinator · +33469856440
  • Clinique Francois Chenieux ( Site 3006), Limoges, Haute-Vienne, France

    Study coordinator · +33555058606
  • Institut Regional du Cancer Montpellier ( Site 3009), Montpellier, Herault, France

    Study coordinator · +33(0)4 67 61 45 65
  • Institut De Cancerologie De L Ouest ( Site 3003), Saint-Herblain, Loire-Atlantique, France

    Study coordinator · +33240679900
  • Institut Jean Godinot ( Site 3002), Reims, Marne, France

    Study coordinator · +33326504444
  • Centre Henri Becquerel ( Site 3001), Rouen, Seine-Maritime, France

    Study coordinator · +33232082575
  • HIA Sainte Anne ( Site 3007), Toulon, Var, France

    Study coordinator · +33483162010
  • Groupe Hospitalier Paris Saint Joseph ( Site 3010), Paris, France

    Study coordinator · +33144123577
  • Hôpital Européen Georges Pompidou ( Site 3011), Paris, France

    Study coordinator · +33156093577
  • Universitatsklinikum Erlangen ( Site 4302), Erlangen, Bavaria, Germany

    Study coordinator · +4991318544082
  • Luisenkrankenhaus Düsseldorf ( Site 4305), Düsseldorf, North Rhine-Westphalia, Germany

    Study coordinator · +4921144773360
  • Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik für Senologie/ Brustzentrum ( Site 4304), Essen, North Rhine-Westphalia, Germany

    Study coordinator · +492011740
  • Caritas Klinikum Saarbruecken St. Theresia ( Site 4301), Saarbrücken, Saarland, Germany

    Study coordinator · +496814061345
  • Universitaetsklinikum Leipzig ( Site 4307), Leipzig, Saxony, Germany

    Study coordinator · +4934197109
  • HELIOS Klinikum Berlin-Buch ( Site 4303), Berlin, Germany

    Study coordinator · +4930940153300
  • Aretaieio Hospital ( Site 3900), Athens, Attica, Greece

    Study coordinator · 0030 2107286444
  • University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 3903), Heraklion, Irakleio, Greece

    Study coordinator · 0030 2810392091
  • General University Hospital of Larissa, Oncology Clinic ( Site 3902), Larissa, Thessaly, Greece

    Study coordinator · 0030 2413501636
  • European Interbalkan Medical Center ( Site 3901), Thessaloniki, Greece

    Study coordinator · 0030 2313252011
  • Queen Mary Hospital ( Site 6000), Hong Kong, Hong Kong

    Study coordinator · 39103339
  • Békés Vármegyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 3405), Gyula, Bekes County, Hungary

    Study coordinator · +36 66/526-526
  • Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Onkoterapias Klinika ( Site 3407), Szeged, Csongrád megye, Hungary

    Study coordinator · +3662545404
  • Budapesti Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 3408), Budapest, Pest County, Hungary

    Study coordinator · +36 1 467-3700/1245
  • Országos Onkológiai Intézet-B-Belgyógyászati Onkológiai Osztály ( Site 3406), Budapest, Hungary

    Study coordinator · +36122486003352
  • Rambam Health Care Campus ( Site 3700), Haifa, Israel

    Study coordinator · +97247772688
  • Shaare Zedek Medical Center ( Site 3704), Jerusalem, Israel

    Study coordinator · +97226555999
  • Rabin Medical Center ( Site 3702), Petah Tikva, Israel

    Study coordinator · +97239377377
  • Sheba Medical Center ( Site 3701), Ramat Gan, Israel

    Study coordinator · +97235303030
  • Sourasky Medical Center ( Site 3703), Tel Aviv, Israel

    Study coordinator · +97236974444
  • Istituto Nazionale Tumori Regina Elena ( Site 4607), Rome, Roma, Italy

    Study coordinator · +39 0652665610
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 4605), Bologna, Italy

    Study coordinator · 390512144547
  • Ospedale Policlinico San Martino ( Site 4606), Genova, Italy

    Study coordinator · +390105600387
  • IRCCS Ospedale San Raffaele ( Site 4600), Milan, Italy

    Study coordinator · 390226436530
  • Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 4601), Milan, Italy

    Study coordinator · +39 02-2390-2849
  • Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 4604), Novara, Italy

    Study coordinator · 3903213732148
  • Istituto Oncologico Veneto IRCCS ( Site 4603), Padova, Italy

    Study coordinator · 0498215523
  • Policlincio Gemelli ( Site 4602), Roma, Italy

    Study coordinator · 0630158545
  • Aichi Cancer Center ( Site 5117), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-762-6111
  • Nagoya City University Hospital ( Site 5108), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-851-5511
  • National Hospital Organization Shikoku Cancer Center ( Site 5122), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • Hokkaido University Hospital ( Site 5100), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-716-1161
  • Kanazawa Medical University Hospital ( Site 5127), Kahoku-gun, Ishikawa-ken, Japan

    Study coordinator · +81-76-286-3511
  • Tokai University Hospital ( Site 5107), Isehara, Kanagawa, Japan

    Study coordinator · +81-463-93-1121
  • St. Marianna University Hospital ( Site 5124), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Kitasato University Hospital ( Site 5123), Sagamihara, Kanagawa, Japan

    Study coordinator · +81-42-778-8111
  • Kanagawa Cancer Center ( Site 5106), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Mie University Hospital ( Site 5109), Tsu, Mie-ken, Japan

    Study coordinator · +81-59-231-5246
  • Naha Nishi Clinic ( Site 5125), Naha, Okinawa, Japan

    Study coordinator · +81-98-858-5557
  • The University of Osaka Hospital ( Site 5111), Suita, Osaka, Japan

    Study coordinator · +81-6-6210-8290
  • Saitama Medical University International Medical Center ( Site 5116), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111
  • Juntendo University Hospital ( Site 5104), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3813-3111
  • Cancer Institute Hospital of JFCR ( Site 5102), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Toranomon Hospital ( Site 5126), Minato, Tokyo, Japan

    Study coordinator · +81-3-3588-1111
  • Showa Medical University Hospital ( Site 5103), Shinagawa, Tokyo, Japan

    Study coordinator · +81-3-3784-8000
  • Tokyo Medical University Hospital ( Site 5121), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • National Center for Global Health and Medicine ( Site 5105), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3202-7181
  • Akita University Hospital ( Site 5115), Akita, Japan

    Study coordinator · +81-18-834-1111
  • National Hospital Organization Kyushu Cancer Center ( Site 5119), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Fukushima Medical University Hospital ( Site 5101), Fukushima, Japan

    Study coordinator · +81-24-547-1772
  • Hiroshima City Hiroshima Citizens Hospital ( Site 5113), Hiroshima, Japan

    Study coordinator · +81-81-221-2291
  • Social medical corporation Hakuaikai Sagara Hospital ( Site 5114), Kagoshima, Japan

    Study coordinator · +81-99-224-1800
  • Kyoto University Hospital ( Site 5110), Kyoto, Japan

    Study coordinator · +81-75-751-3111
  • Okayama University Hospital ( Site 5118), Okayama, Japan

    Study coordinator · +81-86-223-7151
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 5112), Osaka, Japan

    Study coordinator · +81-06-6945-1181
  • National Cancer Institute ( Site 5401), Putrajaya, Putrajaya, Malaysia

    Study coordinator · +60388925418
  • Sarawak General Hospital ( Site 5400), Kuching, Sarawak, Malaysia

    Study coordinator · +6082276820
  • Pantai Hospital Kuala Lumpur ( Site 5402), Kuala Lumpur, Malaysia

    Study coordinator · +60322960888
  • University Malaya Medical Centre ( Site 5403), Kuala Lumpur, Malaysia

    Study coordinator · +60479492351
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 2504), Guadalajara, Jalisco, Mexico

    Study coordinator · 3330447001
  • Grupo Médico ASSET ( Site 2507), Mexico City, Mexico City, Mexico

    Study coordinator · 2223813254
  • COI Centro Oncologico Internacional S.A.P.I. de C.V. ( Site 2514), Mexico City, Mexico City, Mexico

    Study coordinator · +525554248970
  • Centro Oncologico de Alta Especialidad, S.C. ( Site 2509), Mexico City, Mexico City, Mexico

    Study coordinator · +52 55 5286 5738
  • Higiea Oncologia ( Site 2505), Mexico City, Mexico City, Mexico

    Study coordinator · +525554137773
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 2501), Monterrey, Nuevo León, Mexico

    Study coordinator · +528125761529
  • Oncare - Unidad Valle ( Site 2502), San Pedro Garza García, Nuevo León, Mexico

    Study coordinator · +528115337180
  • Centro de Investigacion Clinica de Oaxaca ( Site 2503), Oaxaca City, Oaxaca, Mexico

    Study coordinator · +529516035559
  • Centro de Investigación Oncológica Galerías SC ( Site 2511), Aguascalientes, Mexico

    Study coordinator · +524496890593
  • Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 2510), Chihuahua City, Mexico

    Study coordinator · 526144253458712
  • Centro Potosino de Investigación Médica ( Site 2512), San Luis Potosí City, Mexico

    Study coordinator · 52 444 475 2715
  • Ziekenhuis Rijnstate ( Site 4501), Arnhem, Gelderland, Netherlands

    Study coordinator · +31880056201
  • Zuyderland Medical Centre ( Site 4507), Sittard Geleen, Limburg, Netherlands

    Study coordinator · +31884590400
  • ETZ Elisabeth ( Site 4504), Tilburg, North Brabant, Netherlands

    Study coordinator · +31132210425
  • Deventer Ziekenhuis ( Site 4503), Deventer, Overijssel, Netherlands

    Study coordinator · +31570596437
  • Erasmus Medisch Centrum ( Site 4505), Rotterdam, South Holland, Netherlands

    Study coordinator · +31107041733
  • Meander Medisch Centrum ( Site 4500), Amersfoort, Utrecht, Netherlands

    Study coordinator · +31338507278
  • Martini Ziekenhuis ( Site 4502), Groningen, Netherlands

    Study coordinator · +31505246311
  • Harbour Cancer & Wellness ( Site 5600), Newmarket, Auckland, New Zealand

    Study coordinator · +64 9 220 3333
  • Bowen Icon Cancer Centre ( Site 5601), Crofton Downs, Wellington Region, New Zealand

    Study coordinator · +64 9 479 2069
  • Clínica Internacional - Sede San Borja ( Site 2604), Lima, Peru

    Study coordinator · +51 992004083
  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 2601), Lima, Peru

    Study coordinator · +51 997881134
  • Oncosalud ( Site 2600), Lima, Peru

    Study coordinator · +5115137900
  • Hospital Militar Central Coronel Luis Arias Schereiber ( Site 2603), Lima, Peru

    Study coordinator · +5112443453
  • Mary Mediatrix Medical Center ( Site 5702), Lipa, Batangas, Philippines

    Study coordinator · (043) 773 6800
  • THE MEDICAL CITY ILOILO ( Site 5704), Iloilo City, Philippines

    Study coordinator · +6333 3397340
  • Wielkopolskie Centrum Onkologii-Oddział Onkologii Klinicznej i Immunoonkologii z Pododdziałem Dzien ( Site 3811), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48618850620
  • Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 3802), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

    Study coordinator · +48523743525
  • Pratia MCM Krakow ( Site 3812), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · +48122954100
  • Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 3801), Siedlce, Masovian Voivodeship, Poland

    Study coordinator · +48256403301
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Piersi i Chirurgii ( Site 3803), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · 48225462522
  • Mazowiecki Szpital Onkologiczny ( Site 3807), Wieliszew, Masovian Voivodeship, Poland

    Study coordinator · +48227661500
  • Bialostockie Centrum Onkologii ( Site 3810), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · +48733100322
  • Szpitale Pomorskie Sp. z o. o. ( Site 3805), Gdynia, Pomeranian Voivodeship, Poland

    Study coordinator · +48587260380
  • Szpital Wojewodzki im.M.Kopernika. ( Site 3800), Koszalin, West Pomeranian Voivodeship, Poland

    Study coordinator · 48943488931
  • Institutul Oncologic Cluj ( Site 4701), Cluj-Napoca, Cluj, Romania

    Study coordinator · +40264598362
  • S.C. Radiotherapy Center Cluj S.R.L ( Site 4705), Comuna Floresti, Cluj, Romania

    Study coordinator · +40219368
  • Centrul de Oncologie "Sfântul Nectarie" ( Site 4702), Craiova, Dolj, Romania

    Study coordinator · +40731604432
  • Spitalul Municipal Schuller Ploiești ( Site 4707), Ploieşti, Prahova, Romania

    Study coordinator · +40723943507
  • Cabinet Medical Oncomed ( Site 4704), Timișoara, Timiș County, Romania

    Study coordinator · +40356460995
  • Spitalul Clinic Filantropia ( Site 4703), Bucharest, Romania

    Study coordinator · +40213188930
  • Centrul Medical Neolife- Baneasa ( Site 4706), Bucharest, Romania

    Study coordinator · +40219230
  • National Cancer Center ( Site 5202), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · +82319201623
  • Seoul National University Bundang Hospital ( Site 5204), Seongnam, Kyonggi-do, South Korea

    Study coordinator · 82317877022
  • Kyungpook National University Chilgok Hospital ( Site 5205), Daegu, Taegu-Kwangyokshi, South Korea

    Study coordinator · 82532002625
  • Seoul National University Hospital ( Site 5200), Seoul, South Korea

    Study coordinator · +82220720850
  • Severance Hospital Yonsei University Health System ( Site 5201), Seoul, South Korea

    Study coordinator · +82222288135
  • Samsung Medical Center ( Site 5203), Seoul, South Korea

    Study coordinator · 82234106488
  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 4104), Seville, Andalusia, Spain

    Study coordinator · 34955013068
  • ICO L Hospitalet ( Site 4101), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · +34932607744
  • Hospital Clinico San Carlos ( Site 4100), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · 34913303000/7768
  • Hospital General Universitario de Valencia ( Site 4102), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · 34963131800/438139
  • Parc de Salut Mar - Hospital del Mar ( Site 4106), Barcelona, Spain

    Study coordinator · 34932483860
  • Hospital Beata María Ana ( Site 4105), Madrid, Spain

    Study coordinator · 914097423/303
  • Hospital Universitario Ramon y Cajal ( Site 4103), Madrid, Spain

    Study coordinator · 913368263
  • Taichung Veterans General Hospital ( Site 5303), Taichung, Taiwan

    Study coordinator · +886-4-2359-2525
  • National Cheng Kung University Hospital ( Site 5304), Tainan, Taiwan

    Study coordinator · +886-6-235-3535
  • National Taiwan University Hospital ( Site 5300), Taipei, Taiwan

    Study coordinator · +886-2-23123456
  • Mackay Memorial Hospital ( Site 5301), Taipei, Taiwan

    Study coordinator · +886-2-25433535
  • Chang Gung Memorial Hospital ( Site 5302), Taoyuan, Taiwan

    Study coordinator · +886-3-328-1200
  • Faculty of Medicine Siriraj Hospital ( Site 5800), Bangkoknoi, Bangkok, Thailand

    Study coordinator · +6624192938
  • Songklanagarind hospital ( Site 5801), Hat Yai, Changwat Songkhla, Thailand

    Study coordinator · +6674451469
  • Faculty of Medicine - Khon Kaen University ( Site 5802), Khon Kaen, Thailand

    Study coordinator · +6643363746
  • Ege Universitesi Hastanesi ( Site 4803), Bornova, İzmir, Turkey (Türkiye)

    Study coordinator · 0 232 343 4 343
  • Adana Medical Park Seyhan Hastanesi ( Site 4804), Adana, Turkey (Türkiye)

    Study coordinator · +90 5056166338
  • Hacettepe Universite Hastaneleri ( Site 4800), Ankara, Turkey (Türkiye)

    Study coordinator · 903123052929
  • Gazi University Health Research and Application Center Gazi Hospital ( Site 4805), Ankara, Turkey (Türkiye)

    Study coordinator · 903122158710
  • Sakarya Egitim Arastirma Hsatanesi ( Site 4809), Sakarya, Turkey (Türkiye)

    Study coordinator · 90 505 478 5576
  • Samsun Medical Park Hastanesi ( Site 4810), Samsun, Turkey (Türkiye)

    Study coordinator · 444 44 84
  • Royal Cornwall Hospital ( Site 4003), Truro, Cornwall, United Kingdom

    Study coordinator · +441872258342
  • St Bartholomew's Hospital ( Site 4001), London, London, City of, United Kingdom

    Study coordinator · 02073777000
  • University College London Hospital ( Site 4007), London, London, City of, United Kingdom

    Study coordinator · +447977175703
  • Nottingham University Hospital NHS Trust ( Site 4009), Nottingham, Nottinghamshire, United Kingdom

    Study coordinator · +441159691169
  • Musgrove Park Hospital ( Site 4005), Taunton, Somerset, United Kingdom

    Study coordinator · +441823343634
  • Queen Elizabeth Hospital Birmingham ( Site 4017), Birmingham, United Kingdom

    Study coordinator · +441213718766
  • Velindre Cancer Centre Hospital ( Site 4008), Cardiff, United Kingdom

    Study coordinator · +442920615888
  • St. James s University Hospital ( Site 4004), Leeds, United Kingdom

    Study coordinator · +441132068186
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC